Women in Oncology: How Has the Culture of Oncology Practice Changed Regarding Gender Disparities?

Video

Laura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, share insight on how the corporate culture has changed in oncology practices with regard to gender inequality.

Laura Farrington, DO, a medical oncologist at CTCA Chicago; Elesyia Outlaw-Evans, MD, a radiation oncologist at CTCA Pheonix; and Ruchi Garg, MD, CTCA Program Director of Gynecologic Oncology and gynecologic oncologist at CTCA Atlanta, share insight on how the corporate culture has changed in oncology practices with regard to gender inequality.

The 3 experts sat down to be candid and discuss their variety of experiences throughout their career, what the culture of their work environments were like, the obstacles they came into contact with and how they overcame them, and how society has changed from their early days until now.

Notably, in this exclusive interview, they highlight advice to up-and-upcoming female oncologists on navigating these waters today.

In this episode, the 3 experts discuss in detail how they believe the corporate culture of oncology practices have evolved over the years as it relates to gender-related disparities, and what work still needs to be done in this area.


Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine